Barry Michaels to Retire as Organovo Chief Financial Officer
Jan 19, 2016 13:05 pm UTC| Business
SAN DIEGO, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting...
Organovo Announces Release Date for Fiscal Third-Quarter 2016 Financial Results
Jan 19, 2016 13:05 pm UTC| Business
SAN DIEGO, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting...
Bellerophon Therapeutics Receives EC Certification for New INOpulse® Drug-Device Delivery System
Jan 19, 2016 13:03 pm UTC| Business
WARREN, N.J., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it has received EC Certification for its proprietary new,...
German American Bancorp, Inc. (GABC) Announces 6% Increase in Quarterly Cash Dividend
Jan 19, 2016 13:02 pm UTC| Business
JASPER, Ind., Jan. 19, 2016 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (NASDAQ:GABC) today reported that the Company has declared a quarterly cash dividend of $0.18 per share, representing approximately a 6%...
Vodis Announces Debt Settlement With Director
Jan 19, 2016 13:00 pm UTC| Business
VANCOUVER, British Columbia, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Vodis Pharmaceuticals Inc. (CSE:VP) (FSE:1JV) ("Vodis" or the "Company") announces it has agreed to settle a total of $79,274 in outstanding debt owed to a...
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome
Jan 19, 2016 13:00 pm UTC| Business
EMERYVILLE, Calif., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced receipt of...
Jan 19, 2016 13:00 pm UTC| Business
WIXOM, Mich., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative...